268 related articles for article (PubMed ID: 33524524)
1. Neonatal and pediatric oral drug delivery: Hopes and hurdles.
Mfoafo KA; Omidian M; Bertol CD; Omidi Y; Omidian H
Int J Pharm; 2021 Mar; 597():120296. PubMed ID: 33524524
[TBL] [Abstract][Full Text] [Related]
2. Drug Formulations: Standards and Novel Strategies for Drug Administration in Pediatrics.
Thabet Y; Klingmann V; Breitkreutz J
J Clin Pharmacol; 2018 Oct; 58 Suppl 10():S26-S35. PubMed ID: 30248193
[TBL] [Abstract][Full Text] [Related]
3. Patent landscape of pediatric-friendly oral dosage forms and administration devices.
Karavasili C; Gkaragkounis A; Fatouros DG
Expert Opin Ther Pat; 2021 Jul; 31(7):663-686. PubMed ID: 33605825
[TBL] [Abstract][Full Text] [Related]
4. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.
Giacoia GP; Taylor-Zapata P; Zajicek A
Clin Ther; 2012 Nov; 34(11):S1-10. PubMed ID: 23149008
[TBL] [Abstract][Full Text] [Related]
5. Issues impacting therapeutic outcomes in pediatric patients: an overview.
Kalra A; Goindi S
Curr Pediatr Rev; 2014; 10(3):184-93. PubMed ID: 25088338
[TBL] [Abstract][Full Text] [Related]
6. 10 years EU regulation of pediatric medicines - impact on cardiovascular drug formulations.
Thabet Y; Slavkova M; Breitkreutz J
Expert Opin Drug Deliv; 2018 Mar; 15(3):261-270. PubMed ID: 29284286
[TBL] [Abstract][Full Text] [Related]
7. Orodispersible tablets for pediatric drug delivery: current challenges and recent advances.
Wiedey R; Kokott M; Breitkreutz J
Expert Opin Drug Deliv; 2021 Dec; 18(12):1873-1890. PubMed ID: 34822316
[TBL] [Abstract][Full Text] [Related]
8. Orodispersible drug formulations for children and elderly.
Slavkova M; Breitkreutz J
Eur J Pharm Sci; 2015 Jul; 75():2-9. PubMed ID: 25736528
[TBL] [Abstract][Full Text] [Related]
9. Age-appropriate and acceptable paediatric dosage forms: Insights into end-user perceptions, preferences and practices from the Children's Acceptability of Oral Formulations (CALF) Study.
Ranmal SR; Cram A; Tuleu C
Int J Pharm; 2016 Nov; 514(1):296-307. PubMed ID: 27863675
[TBL] [Abstract][Full Text] [Related]
10. Orally disintegrating films and mini-tablets-innovative dosage forms of choice for pediatric use.
Preis M
AAPS PharmSciTech; 2015 Apr; 16(2):234-41. PubMed ID: 25739913
[TBL] [Abstract][Full Text] [Related]
11. Critical Reviews on Pediatric Dosage Form Developments and Medical Devices.
Kaur G; Nagpal D; Nagpal K
Crit Rev Ther Drug Carrier Syst; 2020; 37(6):553-590. PubMed ID: 33426833
[TBL] [Abstract][Full Text] [Related]
12. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatric Formulation Initiative: selected reports from working groups.
Giacoia GP; Taylor-Zapata P; Mattison D
Clin Ther; 2008 Nov; 30(11):2097-101. PubMed ID: 19108797
[TBL] [Abstract][Full Text] [Related]
13. Mini-tablets: a contemporary system for oral drug delivery in targeted patient groups.
Aleksovski A; Dreu R; Gašperlin M; Planinšek O
Expert Opin Drug Deliv; 2015 Jan; 12(1):65-84. PubMed ID: 25200881
[TBL] [Abstract][Full Text] [Related]
14. Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms.
Lopez FL; Ernest TB; Tuleu C; Gul MO
Expert Opin Drug Deliv; 2015; 12(11):1727-40. PubMed ID: 26165848
[TBL] [Abstract][Full Text] [Related]
15. Oral drug delivery in personalized medicine: unmet needs and novel approaches.
Wening K; Breitkreutz J
Int J Pharm; 2011 Feb; 404(1-2):1-9. PubMed ID: 21070842
[TBL] [Abstract][Full Text] [Related]
16. Drug delivery and formulations.
Breitkreutz J; Boos J
Handb Exp Pharmacol; 2011; 205():91-107. PubMed ID: 21882107
[TBL] [Abstract][Full Text] [Related]
17. A Wish List for Drug Development in Pediatrics.
Meyers R
J Pharm Sci; 2020 Feb; 109(2):939-943. PubMed ID: 31676269
[TBL] [Abstract][Full Text] [Related]
18. Pediatric drug formulations: a review of challenges and progress.
Ivanovska V; Rademaker CM; van Dijk L; Mantel-Teeuwisse AK
Pediatrics; 2014 Aug; 134(2):361-72. PubMed ID: 25022739
[TBL] [Abstract][Full Text] [Related]
19. Pediatric Oral Formulations: An Updated Review of Commercially Available Pediatric Oral Formulations Since 2007.
Strickley RG
J Pharm Sci; 2019 Apr; 108(4):1335-1365. PubMed ID: 30447227
[TBL] [Abstract][Full Text] [Related]
20. Lack of pediatric drug formulations.
Nahata MC
Pediatrics; 1999 Sep; 104(3 Pt 2):607-9. PubMed ID: 10469800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
